# High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting

Study · id `cardio:ct-nct03079115` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03079115](<https://clinicaltrials.gov/study/NCT03079115>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03079115

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 130 participants.

## Technical summary

Registry record NCT03079115. Randomized; single masking; primary purpose treatment. Start 2017-08-21 (actual); primary completion 2020-04-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 130 participants (planned count; ClinicalTrials.gov record NCT03079115, source copy `cardio:ctgov-nct03079115-2020-04-09`, retrieved 2026-10-31)
- Started: 2017-08-21 (actual) (ClinicalTrials.gov record NCT03079115, source copy `cardio:ctgov-nct03079115-2020-04-09`, retrieved 2026-10-31)
- Primary completion: 2020-04-30 (anticipated) (ClinicalTrials.gov record NCT03079115, source copy `cardio:ctgov-nct03079115-2020-04-09`, retrieved 2026-10-31)
- Completion: 2020-04-30 (anticipated) (ClinicalTrials.gov record NCT03079115, source copy `cardio:ctgov-nct03079115-2020-04-09`, retrieved 2026-10-31)
- Countries: China (ClinicalTrials.gov record NCT03079115, source copy `cardio:ctgov-nct03079115-2020-04-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03079115-2020-04-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting
- Acronym: PICAS
- Condition: Carotid Artery Stenosis
- Intervention (Drug): High-dose Atorvastatin
- Intervention (Drug): Conventional-dose Atorvastatin
- Lead sponsor: Beijing Hospital
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

## Provenance

Content hash: 391cee25d2f09597af712b5226eab084585c3ae06d7da3e22499bd3f1b1accd2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
